1. Home
  2. RUN vs RCUS Comparison

RUN vs RCUS Comparison

Compare RUN & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrun Inc.

RUN

Sunrun Inc.

HOLD

Current Price

$12.47

Market Cap

3.1B

Sector

Miscellaneous

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$27.43

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RUN
RCUS
Founded
2007
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.8B
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
RUN
RCUS
Price
$12.47
$27.43
Analyst Decision
Buy
Buy
Analyst Count
20
11
Target Price
$18.80
$30.27
AVG Volume (30 Days)
7.6M
999.3K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
113.35
N/A
EPS
1.71
N/A
Revenue
$858,578,000.00
$247,000,000.00
Revenue This Year
$2.81
N/A
Revenue Next Year
$4.54
$45.62
P/E Ratio
$6.87
N/A
Revenue Growth
12.97
N/A
52 Week Low
$5.38
$7.06
52 Week High
$22.44
$26.40

Technical Indicators

Market Signals
Indicator
RUN
RCUS
Relative Strength Index (RSI) 44.75 68.87
Support Level $12.01 $19.62
Resistance Level $13.57 N/A
Average True Range (ATR) 0.69 1.56
MACD 0.01 0.38
Stochastic Oscillator 24.75 84.77

Price Performance

Historical Comparison
RUN
RCUS

About RUN Sunrun Inc.

Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: